Have a Little Fun!

Respiratory Diseases/Disorders

The FDA has approved the NovoTTF-100L System (Novocure) in combination with pemetrexed plus platinum-based chemotherapy for the first-line treatment of unresectable, locally advanced or metastatic, malignant pleural mesothelioma.

Patients with COPD who have the most severe airflow obstructions according to the GOLD strategy document had more exacerbations than those with less severe obstructions, and were more likely to be treated with both systemic corticosteroids and antibiotics.

Individuals with moderate to very severe COPD and cardiovascular risk factors did not have an increased risk for all-cause mortality or major adverse cardiovascular event occurrence with the use of aclidinium.